BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 1802486)

  • 1. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
    Fridolf T; Ahrén B
    Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
    Fridolf T; Ahrén B
    Biochem Biophys Res Commun; 1991 Aug; 179(1):701-6. PubMed ID: 1883392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms by which gastrin releasing peptide potentiates glucose-induced insulin secretion from mouse islets.
    Gregersen S; Ahrén B
    Pancreas; 1996 Jan; 12(1):48-57. PubMed ID: 8927619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence on extracellular Ca2+ for the effects of cholecystokinin-8 in rat pancreatic islets.
    Karlsson S; Ahrén B
    Diabetes Res; 1991 Mar; 16(3):139-43. PubMed ID: 1666346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
    Fridolf T; Ahrén B
    Mol Cell Endocrinol; 1993 Oct; 96(1-2):85-90. PubMed ID: 8276143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical mechanisms involved in monomethyl succinate-induced insulin secretion.
    Zawalich WS; Zawalich KC
    Endocrinology; 1992 Aug; 131(2):649-54. PubMed ID: 1322278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
    Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
    Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
    Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
    Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
    Weir GC; Mojsov S; Hendrick GK; Habener JF
    Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
    Zawalich WS; Zawalich KC
    Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).
    Lu M; Wheeler MB; Leng XH; Boyd AE
    Endocrinology; 1993 Jan; 132(1):94-100. PubMed ID: 8380389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin gene-related peptide inhibits insulin secretion studies on ion fluxes and cyclic AMP in isolated rat islets.
    Pettersson M; Ahrén B
    Diabetes Res; 1990 Sep; 15(1):9-14. PubMed ID: 1966731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
    García-Flores M; Zueco JA; Alvarez E; Blázquez E
    Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
    Göke R; Wagner B; Fehmann HC; Göke B
    Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.